Macrophage Migration Inhibitor Factor Upregulates MCP-1 Expression in an Autocrine Manner in Hepatocytes during Acute Mouse Liver Injury

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Xie, Jieshi ^a   Yang, Le ^a   Tian, Lei ^a   Li, Weiyang ^a   Yang, Lin ^a   Li, Liying ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARBON TETRACHLORIDE; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN KINASE INHIBITOR;

ANIMAL; AUTOCRINE EFFECT; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; LIVER CELL; LIVER DISEASE; METABOLISM; MOUSE; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TOXIC HEPATITIS;

ANIMALS; AUTOCRINE COMMUNICATION; BIOMARKERS; CARBON TETRACHLORIDE; CHEMICAL AND DRUG INDUCED LIVER INJURY; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HEPATOCYTES; LIVER DISEASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84973618754     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep27665     Document Type: Article

References (52)

1. Godoy, P. et al. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and nonparenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol 87, 1315-530 (2013).
2. Malhi, H., Guicciardi, M. E. & Gores, G. J. Hepatocyte death: a clear and present danger. Physiol Rev 90, 1165-94 (2010).
3. Barnes, M. A. et al. Macrophage migration inhibitory factor contributes to ethanol-induced liver injury by mediating cell injury, steatohepatitis, and steatosis. Hepatology 57, 1980-91 (2013).
4. Patel, S. J. et al. Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure. Nat Biotechnol 30, 179-83 (2012).
5. Park, S. H. & Rehermann, B. Immune responses to HCV and other hepatitis viruses. Immunity 40, 13-24 (2014).
6. Sheng, L., Jiang, B. & Rui, L. Intracellular lipid content is a key intrinsic determinant for hepatocyte viability and metabolic and inflammatory states in mice. Am J Physiol Endocrinol Metab 305, E1115-23 (2013).
7. El-Halawany, A. M., El, D. R., El, S. N. & Hattori, M. Protective effect of Aframomum melegueta phenolics against CCl(4)-induced rat hepatocytes damage; role of apoptosis and pro-inflammatory cytokines inhibition. Sci. Rep 4, 5880 (2014).
8. Bloom, J. & Al-Abed, Y. MIF: mood improving/inhibiting factor? J Neuroinflammation 11, 11 (2014).
9. van der Vorst, E. P., Doring, Y. & Weber, C. MIF and CXCL12 in Cardiovascular Diseases: Functional Differences and Similarities. Front Immunol 6, 373 (2015).
10. Calandra, T. & Roger, T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3, 791-800 (2003).
11. Makita, H. et al. Effect of anti-macrophage migration inhibitory factor antibody on lipopolysaccharide-induced pulmonary neutrophil accumulation. Am J Respir Crit Care Med 158, 573-9 (1998).
12. Xiong, C., Huang, B., Cun, Y., Aghdasi, B. G. & Zhou, Y. Migration inhibitory factor enhances inflammation via CD74 in cartilage end plates with Modic type 1 changes on MRI. Clin Orthop Relat Res. 472, 1943-54 (2014).
13. Veillat, V. et al. Macrophage migration inhibitory factor elicits an angiogenic phenotype in human ectopic endometrial cells and triggers the production of major angiogenic factors via CD44, CD74, and MAPK signaling pathways. J Clin Endocrinol Metab 95, E403-12 (2010).
14. Hu, C. T. et al. MIF, secreted by human hepatic sinusoidal endothelial cells, promotes chemotaxis and outgrowth of colorectal cancer in liver prometastasis. Oncotarget 6, 22410-23 (2015).
15. Kumagi, T., Akbar, F., Horiike, N. & Onji, M. Increased serum levels of macrophage migration inhibitory factor in alcoholic liver diseases and their expression in liver tissues. Clin Biochem 34, 189-93 (2001).
16. Assis, D. N. et al. The role of macrophage migration inhibitory factor in autoimmune liver disease. Hepatology 59, 580-91 (2014).
17. Hori, Y. et al. Immunohistochemical study of macrophage migration inhibitory factor in rat liver fibrosis induced by thioacetamide. Eur J Histochem 47, 317-24 (2003).
18. Shi, X. et al. CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 25, 595-606 (2006).
19. Sanchez-Nino, M. D. et al. The MIF receptor CD74 in diabetic podocyte injury. J Am Soc Nephrol 20, 353-62 (2009).
20. Panee, J. Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes. Cytokine 60, 1-12 (2012).
21. Deshmane, S. L., Kremlev, S., Amini, S. & Sawaya, B. E. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 29, 313-26 (2009).
22. Baeck, C. et al. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut 61, 416-26 (2012).
23. Zamara, E. et al. Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice. J Hepatol 46, 230-8 (2007).
24. Mandrekar, P., Ambade, A., Lim, A., Szabo, G. & Catalano, D. An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice. Hepatology 54, 2185-97 (2011).
25. Charo, I. F. & Taubman, M. B. Chemokines in the pathogenesis of vascular disease. Circ Res 95, 858-66 (2004).
26. Banerjee, A., Abdelmegeed, M. A., Jang, S. & Song, B. J. Increased Sensitivity to Binge Alcohol-Induced Gut Leakiness and Inflammatory Liver Disease in HIV Transgenic Rats. PLoS One 10, e0140498 (2015).
27. Na, T. Y. et al. 22-S-Hydroxycholesterol protects against ethanol-induced liver injury by blocking the auto/paracrine activation of MCP-1 mediated by LXRalpha. J Pathol 235, 710-20 (2015).
28. Gunes, H. et al. Relationship among MIF, MCP-1, viral loads, and HBs Ag levels in chronic hepatitis B patients. Turk J Med Sci 45, 634-7 (2015).
29. Zhang, B. et al. Macrophage migration inhibitory factor contributes to hypoxic pulmonary vasoconstriction in rats. Microvasc Res 83, 205-12 (2012).
30. Ma, H. et al. Impaired macrophage migration inhibitory factor-AMP-activated protein kinase activation and ischemic recovery in the senescent heart. Circulation 122, 282-92 (2010).
31. Gao, G. et al. TRPM2 mediates ischemic kidney injury and oxidant stress through RAC1. J Clin Invest 124, 4989-5001 (2014).
32. Csak, T. et al. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology 54, 133-44 (2011).
33. Petrasek, J. et al. Metabolic danger signals, uric acid and ATP, mediate inflammatory cross-talk between hepatocytes and immune cells in alcoholic liver disease. J Leukoc Biol 98, 249-56 (2015).
34. Cohen-Naftaly, M. & Friedman, S. L. Current status of novel antifibrotic therapies in patients with chronic liver disease. Therap Adv Gastroenterol 4, 391-417 (2011).
35. Herkel, J., Schuchmann, M., Tiegs, G. & Lohse, A. W. Immune-mediated liver injury. J Hepatol 42, 920-3 (2005).
36. Kim, J. S., Chopp, M. & Gautam, S. C. High dose methylprednisolone therapy reduces expression of JE/MCP-1 mRNA and macrophage accumulation in the ischemic rat brain. J Neurol Sci. 128, 28-35 (1995).
37. Qi, Z., Wang, X., Wei, H., Sun, R. & Tian, Z. Infiltrating neutrophils aggravate metabolic liver failure in fah-deficient mice. Liver Int 35, 774-85 (2015).
38. Huang, X. R. et al. Macrophage migration inhibitory factor is an important mediator in the pathogenesis of gastric inflammation in rats. Gastroenterology 121, 619-30 (2001).
39. Liu, A., Fang, H., Dirsch, O., Jin, H. & Dahmen, U. Early release of macrophage migration inhibitory factor after liver ischemia and reperfusion injury in rats. Cytokine 57, 150-7 (2012).
40. White, D. A. et al. Pro-inflammatory action of MIF in acute myocardial infarction via activation of peripheral blood mononuclear cells. PLoS One 8, e76206 (2013).
41. Lan, H. Y. et al. Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int 57, 499-509 (2000).
42. Huang, H., Jing, G., Wang, J. J., Sheibani, N. & Zhang, S. X. ATF4 is a novel regulator of MCP-1 in microvascular endothelial cells. J Inflamm (Lond) 12, 31 (2015).
43. Shalini, V., Pushpan, C. K., G. S., A. J. & A. H. Tricin, flavonoid from Njavara reduces inflammatory responses in hPBMCs by modulating the p38MAPK and PI3K/Akt pathways and prevents inflammation associated endothelial dysfunction in HUVECs. Immunobiology 221, 137-44 (2016).
44. Li, J. et al. (-)-Epigallocatechin gallate inhibits endotoxin-induced expression of inflammatory cytokines in human cerebral microvascular endothelial cells. J Neuroinflammation 9, 161 (2012).
45. Yu, X. et al. Macrophage migration inhibitory factor induces MMP-9 expression in macrophages via the MEK-ERK MAP kinase pathway. J Interferon Cytokine Res 27, 103-9 (2007).
46. Pakozdi, A. et al. Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis. Arthritis Res Ther 8, R132 (2006).
47. Yago, T. et al. E-selectin engages PSGL-1 and CD44 through a common signaling pathway to induce integrin alphaLbeta2-mediated slow leukocyte rolling. Blood 116, 485-94 (2010).
48. Nam, K., Oh, S., Lee, K. M., Yoo, S. A. & Shin, I. CD44 regulates cell proliferation, migration, and invasion via modulation of c-Src transcription in human breast cancer cells. Cell Signal 27, 1882-94 (2015).
49. Mai, P. et al. Endocannabinoid System Contributes to Liver Injury and Inflammation by Activation of Bone Marrow-Derived Monocytes/Macrophages in a CB1-Dependent Manner. J Immunol 195, 3390-401 (2015).
50. Tsung, A. et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 201, 1135-43 (2005).
51. Serriere-Lanneau, V. et al. The sphingosine 1-phosphate receptor S1P2 triggers hepatic wound healing. FASEB J 21, 2005-13 (2007).
52. Unitt, E. et al. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology 41, 722-30 (2005).